FDAFDA · Food and drugs·Recall number D-0845-2022
Insulin Glargine (insulin glargine-yfgn) Injection, 100 units/mL (U-100), packaged in a 10 mL Multiple-Dose vial inside a carton, Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Manufactured for: Mylan Specialty L.P., Morgantown, WV 26505, NDC 49502-393-80
Published May 4, 2022 · Recall initiated: April 12, 2022
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Missing label on the vial
What to do
Voluntary: Firm initiated · Press Release
Recall details
- Manufacturer
- Mylan Pharmaceuticals Inc
- Distributor
- USA nationwide.
- Lot
- Lot #: BF21002800, Exp 8/2023
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.